Nanoligent
Pre-clinicalExplore how Nanoligent uses cutting-edge technology to design precision medicines, enhancing treatment efficacy and patient outcomes.
Founded
2017
Focus
BiologicsNanotechnology
About
Explore how Nanoligent uses cutting-edge technology to design precision medicines, enhancing treatment efficacy and patient outcomes.
Funding History
2Total raised: $12.5M
Series A$10MYsios CapitalMay 15, 2023
Seed$2.5MUndisclosedMar 15, 2021
Company Info
TypePrivate
Founded2017
LocationBarcelona, Spain
StagePre-clinical
Contact
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile